Bookbuilding IPO | ₹1,204 Cr | Listed at BSE, NSE | Wed, Apr 3, 2019 - Fri, Apr 5, 2019
Metropolis Healthcare IPO is a book build issue of ₹1,204.29 crores. The issue is entirely an offer for sale of 1.37 crore shares of ₹1,204.29 crore.
Metropolis Healthcare IPO bidding started from Apr 3, 2019 and ended on Apr 5, 2019. The allotment for Metropolis Healthcare IPO was finalized on Apr 10, 2019. The shares got listed on BSE, NSE on Apr 15, 2019.
Metropolis Healthcare IPO price band is set at ₹880 per share. The lot size for an application is 17. The minimum amount of investment required by an retail is ₹14,960 (17 shares) (based on upper price). The lot size investment for sNII is 14 lots (238 shares), amounting to ₹2,09,440, and for bNII, it is 67 lots (1,139 shares), amounting to ₹10,02,320.
The issue includes a reservation of up to 3,00,000 shares for employees offered at a discount of ₹0.00 to the issue price.
Credit Suisse Securities (India) Pvt.Ltd. is the book running lead manager and MUFG Intime India Pvt.Ltd. is the registrar of the issue.
Refer to Metropolis Healthcare IPO RHP for detailed Information.
IPO Open
Wed, Apr 3, 2019
IPO Close
Fri, Apr 5, 2019
Issue Price
₹880 per share
Market Cap (Pre-IPO)
₹4,415.72 Cr
| IPO Date | 3 to 5 Apr, 2019 |
| Listed on | Mon, Apr 15, 2019 |
| Face Value | ₹2 per share |
| Price Band | ₹877 to ₹880 |
| Issue Price | ₹880 per share |
| Lot Size | 17 Shares |
| Sale Type | OFS only |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Total Issue Size | 1,36,85,095 shares (agg. up to ₹1,204 Cr) |
| Offer for Sale | 1,36,85,095 shares of ₹2 (agg. up to ₹1,204 Cr) |
| Share Holding Pre Issue | 5,01,78,680 shares |
| Share Holding Post Issue | 5,01,78,680 shares |
| BSE Script Code / NSE Symbol | 542650 / METROPOLIS |
| ISIN | INE112L01020 |
Metropolis Healthcare IPO comprises a total issue size of 1,36,85,095 shares. The net offer to the public is 1,33,85,095 shares, after excluding 3,00,000 shares under a preferential allotment. Of the Net offer 1,00,38,822 (75.00%) are allocated to QIB, 20,07,764 (15.00%) allocated to NII 13,38,509 (10.00%) allocated to RII.
| Investor Category | Shares Offered | % of Net Issue | % of Total Issue | Max Allottees |
|---|---|---|---|---|
| QIB Shares Offered | 1,00,38,822 | 75.00% | 73.36% | NA |
| − Anchor Investor Shares Offered | 60,23,293 | 44.01% | NA | |
| − QIB (Ex. Anchor) Shares Offered | 40,15,529 | 29.34% | NA | |
| NII (HNI) Shares Offered | 20,07,764 | 15.00% | 14.67% | NA |
| Retail Shares Offered | 13,38,509 | 10.00% | 9.78% | 78,735 |
| Preferential Reservations | ||||
| Employee Shares Offered | 3,00,000 | 2.19% | NA | |
| Total Shares Offered | 1,36,85,095 | 100.00% | 100.00% | |
Investors can bid for a minimum of 17 shares and in multiples thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 17 | ₹14,960 |
| Retail (Max) | 13 | 221 | ₹1,94,480 |
| S-HNI (Min) | 14 | 238 | ₹2,09,440 |
| S-HNI (Max) | 66 | 1,122 | ₹9,87,360 |
| B-HNI (Min) | 67 | 1,139 | ₹10,02,320 |
Metropolis Healthcare IPO raises ₹530.05 crore from anchor investors. Metropolis Healthcare IPO Anchor bid date is April 2, 2019.
📝 Anchor Investors Letter (PDF)
| Bid Date | Tue, Apr 2, 2019 |
| Shares Offered | 60,23,293 |
| Anchor Portion (₹ Cr.) | 530.05 |
| Anchor lock-in period end date for 50% shares (30 Days) | Fri, May 10, 2019 |
| Anchor lock-in period end date for remaining shares (90 Days) | Tue, Jul 9, 2019 |
| Application Category | Maximum Bidding Limits | Bidding at Cut-off Price Allowed |
|---|---|---|
| Only RII | Up to Rs 2 Lakhs | Yes |
| Only sNII | Rs 2 Lakhs to Rs 10 Lakhs | No |
| Only bNII | Rs 10 Lakhs to NII Reservation Portion | No |
| Only employee | Yes | |
| Employee + RII/NII |
|
Yes for Employee and RII/NII |
Incorporated in 1980, Mumbai based Metropolis Healthcare Limited is a chain of diagnostic companies. It has 106 clinical laboratories 1130 collection centres in seven countries. In India, it has laboratories across 18 states and 173 cities for monitoring of disease, early detection, and diagnostic screening.
The company also provides analytical and support services for the clinical research projects to some clinical research organizations. In the last financial year (2018), approximately 7.7 million patients visited the lab and around 16.0 million tests conducted in the clinics.
Metropolis offers 3,480 clinical laboratory tests and 524 profiles which combines a variety of tests for the specific disease. To provide better services, it has implemented a 'hub and spoke' model. Outside India, the company has a presence in Ghana, Zambia, Kenya, Sri Lanka and Mauritius for laboratory operations and in UAE, Nepal, Nigeria, and Oman for 3rd party services.
It has been recognized by Biotrains for "excellence in customer service and delivery" and FICCI for "service excellence (diagnostic center)" and LH Insights for "best in health and fitness" in 2018.
The competitive strengths of the company are:
1. Well positioned for expected industry growth
2. Widespread operational network
3. Comprehensive test menu
4. Focus on quality and customer service
5. Robust information technology structure
| Period Ended |
|---|
| Amount in ₹ Crore |
The Metropolis IPO is subscribed 5.83 times on April 5, 2019 6:49:02 PM (Day 3). The public issue subscribed 2.15 times in the retail category, 8.88 times in the QIB category, and 3.03 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) | Shares Offered | Shares bid for |
|---|---|---|---|
| QIB | 8.88 | 40,15,529 | 3,56,53,386 |
| NII | 3.03 | 20,07,764 | 60,86,306 |
| Retail | 2.15 | 13,38,509 | 28,78,049 |
| Employee | 0.05 | 3,00,000 | 16,235 |
| Total | 5.83 | 76,61,802 | 4,46,33,976 |
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Fees payable to the BRLMs (including brokerage, underwriting and selling commission) | 2.46 |
| 2 | Brokerage, selling commission and bidding charges for members of the Syndicate, SCSBs, CRTAs and CDPs; selling commission and Processing fees to SCSBs and Sponsor Bank for ASBA Applications procured by the Syndicate, sub-syndicate, Registered Brokers, CRTAs or CDPs and submitted with the SCSBs; and Bidding Charges to members of the Syndicate, CRTAs and CDPs; selling commission for Registered Brokers | 0.22 |
| 3 | Fees and expenses payable to Registrar to the Offer | 0.04 |
| 4 | Printing and stationery expenses | 0.21 |
| 5 | Advertising and marketing expenses | 0.52 |
| 6 | Others: (i) Listing fees; (ii) SEBI, BSE and NSE processing fees; (iii) Book-building software fees; (iv) Other regulatory expenses; (v) Monitoring agency fees; (vi) Fees payable to legal counsels; and (vii) Miscellaneous | 1.57 |
| Price Details | BSE | NSE |
|---|---|---|
| Final Issue Price | ₹880.00 | ₹880.00 |
| Open | ₹960.00 | ₹958.00 |
| Low | ₹934.80 | ₹935.00 |
| High | ₹981.30 | ₹982.70 |
| Last Trade | ₹959.55 | ₹959.85 |
Metropolis Healthcare IPO is a main-board IPO of 1,36,85,095 equity shares of the face value of ₹2 aggregating up to ₹1,204 Crores. The issue is priced at ₹880 per share. The minimum order quantity is 17.
The IPO opens on Wed, Apr 3, 2019, and closes on Fri, Apr 5, 2019.
MUFG Intime India Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Zerodha customers can apply online in Metropolis Healthcare IPO using UPI as a payment gateway. Zerodha customers can apply in Metropolis Healthcare IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Metropolis Healthcare IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Metropolis Healthcare IPO opens on Wed, Apr 3, 2019 and closes on Fri, Apr 5, 2019.
Metropolis Healthcare IPO lot size is 17, and the minimum amount required for application is ₹14,960.
You can apply in Metropolis Healthcare IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Metropolis Healthcare IPO will be done on Wednesday, April 10, 2019, and the allotted shares will be credited to your demat account by Fri, Apr 12, 2019. Check the Metropolis Healthcare IPO allotment status.
The Metropolis Healthcare IPO listing date is on Mon, Apr 15, 2019.
